10-K

Company

KIORA PHARMACEUTICALS INC

Filed

March 31, 2015

Period of Report

December 31, 2014

Accession Number

0001144204-15-020232

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →